Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic – Tracking Global Monkeypox Spread

Chart: Monkeypox status

The data and chart show as of end of July, the highest concentrations of monkeypox cases per 1 million residents are in North America and Europe. . . . → Read More: Infographic – Tracking Global Monkeypox Spread

Univ. Labs Ink Licensing Deals for Covid-19 Tests

Home testing station

Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections. . . . → Read More: Univ. Labs Ink Licensing Deals for Covid-19 Tests

Immune Disease Biotech Acquired in $405M Deal

Human T-cell

A biotechnology developer of treatments for autoimmune disorders with checkpoint receptor proteins is acquired by drug maker Gilead Sciences. . . . → Read More: Immune Disease Biotech Acquired in $405M Deal

Peptide Vaccine Shown to Reduce Harmful Cholesterol

Heart, circulation system

Tests with lab monkeys show a vaccine with a synthetic peptide lowers so-called bad cholesterol in blood for longer periods than a comparable monoclonal antibody. . . . → Read More: Peptide Vaccine Shown to Reduce Harmful Cholesterol

Patent Issued for Anti-Bacterial Viruses with Crispr Payloads

Crispr graphic

A biotechnology company received a patent for its engineered viruses to deliver gene-edited treatments to combat bacterial infections in the microbiome. . . . → Read More: Patent Issued for Anti-Bacterial Viruses with Crispr Payloads

Alzheimer’s Assn Collecting Real-World Therapy Data

Hands of older person

An advocacy group for Alzheimer’s disease care and research is establishing a network for collecting long-term safety and outcomes data from patients in real-world settings. . . . → Read More: Alzheimer’s Assn Collecting Real-World Therapy Data